AlphaCrest Capital Management’s Surgery Partners SGRY Stock Holding History

AlphaCrest Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,906	Closed	-$466K	–	955
2022 Q3	$466K	Sell	19,906 -5,710	-22%	-$182K	0.03%	1008
2022 Q2	$741K	Buy	25,616 +11,913	+87%	+$520K	0.04%	799
2022 Q1	$754K	Buy	+13,703	New	+$678K	0.04%	683
2021 Q4	–	Sell	-7,000	Closed	-$296K	–	1433
2021 Q3	$296K	Buy	7,000 +1,836	+36%	+$93.7K	0.02%	1112
2021 Q2	$344K	Buy	+5,164	New	+$280K	0.01%	1074

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's SGRY Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Surgery Partners (SGRY) in Q4 2022, closing a stake of 19,906 shares — an estimated $466K sold.

AlphaCrest Capital Management first reported a position in SGRY in Q2 2021 and held it in 5 quarters. The position peaked at $754K in Q1 2022. 161 funds tracked by Wall St. Rank hold SGRY as of Q4 2022.

AlphaCrest Capital Management reported no remaining Surgery Partners position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 19,906 Surgery Partners shares in Q4 2022, an estimated $466K.
AlphaCrest Capital Management first reported a position in Surgery Partners in Q2 2021 and held it in 5 quarters.
AlphaCrest Capital Management's Surgery Partners position peaked at $754K in Q1 2022.
161 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.